--- title: "OGN.US (OGN.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/OGN.US/news.md" symbol: "OGN.US" name: "OGN.US" parent: "https://longbridge.com/en/quote/OGN.US.md" datetime: "2026-05-19T22:54:39.936Z" locales: - [en](https://longbridge.com/en/quote/OGN.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/OGN.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/OGN.US/news.md) --- # OGN.US (OGN.US) — Related News ### [Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Brokerages](https://longbridge.com/en/news/286645020.md) *2026-05-16T12:10:31.000Z* > Organon & Co. (NYSE:OGN) has received a consensus rating of 'Reduce' from seven research firms, with three analysts reco ### [Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News](https://longbridge.com/en/news/286556635.md) *2026-05-15T03:30:29.000Z* > Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News ### [17:25 ETAre XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/286471428.md) *2026-05-14T21:25:40.000Z* > Halper Sadeh LLC is investigating XOMA, Organon & Co., and Veris Residential for potential violations of federal securit ### [14:27 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX](https://longbridge.com/en/news/285420865.md) *2026-05-06T18:27:21.000Z* > Class Action Attorney Juan Monteverde with Monteverde & Associates PC is investigating mergers involving Helix Energy So ### [Is It Time To Reassess Organon (OGN) After Its Sharp Recent Share Price Surge?](https://longbridge.com/en/news/285393851.md) *2026-05-06T14:05:58.000Z* > Organon (OGN) has seen a significant share price surge, closing at $13.35, with a 47.6% return over the past year. Despi ### [14:55 ETAre OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/285107946.md) *2026-05-04T18:55:38.000Z* > Halper Sadeh LLC is investigating Organon & Co. (NYSE: OGN), TruBridge, Inc. (NASDAQ: TBRG), and Cyclerion Therapeutics, ### [Organon | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 1.46 B](https://longbridge.com/en/news/285074240.md) *2026-05-04T12:49:08.000Z*